Management of liver tumors from metastatic colorectal cancer (mCRC) presents a complex challenge to oncologists and multidisciplinary treatment teams.

Selective internal radiation therapy (SIRT) with SIR-Spheres® Y-90 resin microspheres is an approved local therapy for the management of unresectable mCRC liver tumors with proven evidence and ongoing clinical research:

  • Over 100,000 doses have been administered in more than 1,300 medical centers worldwide.
  • In addition, recent data from an array of large, multi-center, international studies support expanded use of SIR-Spheres Y-90 resin microspheres in appropriate patients.
  • Sirtex is supporting a clinical research program to further investigate and expand the use of SIR-Spheres Y-90 resin microspheres.


Now leaving

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.



You are now leaving your current region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.